Creo Medical

Creo Medical's mission is to improve patient outcomes by applying its unique Kamaptive Advanced Energy technology to the emerging field of therapeutic endoscopy. The company has achieved commercial traction with its Speedboat devices, demonstrated significant health economic savings for providers like the NHS, and secured a strategic licensing deal with Intuitive Surgical. Its strategy combines innovative device development with a robust clinical education program (Pioneer Programme) to drive adoption and change the standard of care.

Kamaptive Technology: A proprietary Advanced Energy platform that uniquely combines super high frequency microwave and advanced bipolar radiofrequency energy to enable precise cutting, coagulation, and ablation in minimally invasive endoscopic devices.

Creo competes with traditional electrosurgery giants (ERBE, Medtronic) and specialized endoscopic toolmakers (Boston Scientific). Its unique dual-energy Kamaptive platform differentiates it by aiming to offer faster coagulation and more controlled dissection in a single device, potentially simplifying complex procedures like endoscopic submucosal dissection (ESD).